Cite
HARVARD Citation
Mei, S. et al. (2021). PRMT5 promotes progression of endometrioid adenocarcinoma via ERα and cell cycle signaling pathways. Journal of pathology. pp. 154-164. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mei, S. et al. (2021). PRMT5 promotes progression of endometrioid adenocarcinoma via ERα and cell cycle signaling pathways. Journal of pathology. pp. 154-164. [Online].